NeoGenomics Stock Price

-0.09 (-0.36%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 636,463
Bid Price 24.00
Ask Price 26.72
News -
Day High 25.3137


52 Week Range


Day Low 24.03
Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
NeoGenomics Inc NEO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.09 -0.36% 24.90 20:00:01
Open Price Low Price High Price Close Price Prev Close
24.78 24.03 25.3137 24.94 24.99
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
9,365 636,463 $ 24.54 $ 15,620,388 - 24.03 - 61.57
Last Trade Time Type Quantity Stock Price Currency
19:05:47 4 $ 24.55 USD


Draw Mode:

NeoGenomics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.07B 123.12M 101.34M $ 444.45M $ 41.42M 0.03 67.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 312.84k 4.00%

more financials information »

NeoGenomics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NEO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week28.7629.5824.0326.96905,866-3.86-13.42%
1 Month31.3235.4024.0331.951,053,781-6.42-20.5%
3 Months44.7547.1324.0335.54920,718-19.85-44.36%
6 Months45.1954.7424.0341.36906,360-20.29-44.9%
1 Year52.6261.5724.0344.30854,263-27.72-52.68%
3 Years15.1561.5714.8033.80854,1609.7564.36%
5 Years8.5361.577.0827.61717,06116.37191.91%

NeoGenomics Description

NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.